Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Mol Genet Metab. Author manuscript; available in PMC 2010 December 1.
Published in final edited form as:
PMCID: PMC2783206

Developmental Expression Pattern of the Cholesterogenic Enzyme NSDHL and Negative Selection of NSDHL-deficient Cells in the Heterozygous Bpa1H/+ Mouse


NSDHL (NAD(P)H sterol dehydrogenase-like), is a 3β-hydroxysterol dehydrogenase thought to function in the demethylation of sterol precursors in one of the later steps of cholesterol biosynthesis. Mutations in the X-linked NSDHL gene cause CHILD syndrome in humans, and the male-lethal bare patches (Bpa) phenotype in mice. The relative level of NSDHL expression among different mouse tissues at several stages of embryogenesis and postnatal development was analyzed by immunohistochemistry. In wild type (WT) embryos, the highest levels of expression were seen in the liver, dorsal root ganglia, central nervous system, retina, adrenal gland and testis. Heterozygous Bpa1H females are mosaic for NSDHL expression due to normal random X inactivation. NSDHL deficient cells were detected in the developing cerebral cortex and retina of Bpa1H female embryos. In postnatal WT and Bpa1H animals, we compared the expression pattern of NSDHL in skin, an affected tissue; liver, a main site of cholesterol synthesis; and brain, a tissue dependent on endogenous synthesis of cholesterol due to lack of transport across the blood-brain barrier. Clonal populations of mutant cells were visible in the brain, skin and liver of Bpa1H pups. In the liver, the proportion of NSDHL negative cells dropped from ~50% at postnatal day 6 to ~20% at one year of age. In the brain, which showed the highest expression in cerebral cortical and hippocampal neurons, the proportion of NSDHL negative cells also dropped dramatically over the first year of life. Our results suggest that while NSDHL deficient cells in the mosaic Bpa1H female are able to survive and differentiate during embryonic development, they are subject to negative selection over the life of the animal.


Cholesterol is an essential lipid component of animal cell membranes where it affects membrane fluidity. It is enriched in structural domains, such as lipid rafts and caveolae, that influence the localization and trafficking of membrane-bound proteins [1]. Cholesterol homeostasis is mediated through a combination of endogenous biosynthesis and dietary uptake, along with lipid binding proteins and receptors that mediate its transport, storage, catabolism and excretion [2]. The cholesterol biosynthetic pathway involves approximately 20 enzymes, with HMG-CoA reductase (HMGCR) catalyzing the rate-limiting, first committed step. Intermediate molecules in the pathway provide precursors for a variety of other cellular processes, including the prenylation of proteins and the synthesis of heme A, dolichol, vitamin D and oxysterols. Moreover, cholesterol is itself a precursor for the synthesis of steroid hormones and neurosteroids. Finally, the covalent binding of cholesterol to hedgehog proteins, a family of secreted, signaling morphogens with a broad range of functions in development, affects their localization and physical range of activity [3].

Studies of mouse mutants show that the phenotypes resulting from loss of function of cholesterogenic enzymes vary in severity depending on the step of the pathway that is affected, with defects in earlier steps giving more severe phenotypes than those at later steps. For example, loss of HMGCR activity results in early embryonic lethality around the time of implantation, while mutants lacking 7-dehyrocholesterol reductase (DHCR7), the last enzyme of the pathway, die within the first days after birth [46]. This trend is also reflected in humans by a range of defects seen in patients with inherited disorders of cholesterol synthesis [79].

NSDHL (NAD(P)H sterol dehydrogenase-like) is a 3β-hydroxysterol dehydrogenase that is thought to function in C-4 demethylation of sterol intermediates in one of the later steps of the cholesterol biosynthetic pathway [10]. The enzyme is localized to membranes of the endoplasmic reticulum (ER) and the surface of lipid droplets [11]. Mutations in the X-linked Nsdhl gene are responsible for the phenotype of the bare patches (Bpa) and striated (Str) mouse lines [10]. The Bpa1H allele of Nsdhl is defined by a K103X nonsense mutation that is thought to abolish the enzymatic activity and disrupt the normal subcellular localization of the protein (Liu et al 1999; Caldas and Herman, 2003). A majority of affected Bpa1H males die between E7.5 and E9.5, typically displaying grossly abnormal morphology [12, 13]. Heterozygous Bpa1H females are mosaic for the expression of WT and mutant NSDHL due to random X inactivation. The hallmark of affected females is the development hyperkeratotic eruptions in the skin at postnatal day 5 that resolve to hairless patches after 2–3 weeks [14]. They also display skeletal defects, occasional microphthalmia, and, on average, are smaller than wild type (WT) littermates at birth [15]. Mutations in the human NSDHL gene cause CHILD syndrome, a rare disorder causing early embryonic lethality in males, and unilateral skin defects and limb reduction in females [1618].

In light of the early embryonic lethality of Bpa1H males, we wondered about the fate of Bpa1H cells in the mosaic female. Here, we present results from an investigation of the expression pattern of NSDHL in WT mice and Bpa1H females. We used immunohistochemistry to identify NSDHL positive cell types in selected WT tissues, and then asked whether a population of NSDHL negative cells survived in the same tissues in Bpa1H females. We focused on three organs: the liver, because it is a primary site of cholesterol biosynthesis in the body; the skin, because of its striking phenotype in Bpa1H females; and the brain, because of its relatively high cholesterol content and the fact that it is entirely dependent on endogenous cholesterol biosynthesis due to the blood-brain barrier [19]. We found that NSDHL negative cells survive in the Bpa1H mosaic female through embryonic and neonatal development, but that they are then subject to negative selection over the lifetime of the animal.

Material and Methods

Mice and Cells

A breeding stock of Bpa1H mice [12] was maintained by mating heterozygous Bpa1H females to F1 hybrid C57BL/6JAw-J X CBA/CaGnLe (B6CBA) males (The Jackson Laboratory, Bar Harbor, ME). Mice were fed our routine institutional high-fat chow, with no cholesterol (Harlan Teklad Rodent Diet 2919). Bpa1H and WT mouse embryonic fibroblasts (MEFs) were cultured as previously described [20]. Embryos were genotyped for sex and the Bpa1H allele by PCR analysis of yolk sac DNA as previously described [21, 22]. All procedures involving mice conformed to protocols approved by the Institutional Animal Care and Use Committee of the Research Institute at Nationwide Children’s Hospital.


A rabbit polyclonal antiserum was generated using the peptide antigen DEAVERTVQSFHHLRKDK corresponding to amino acid residues 345–362 of mouse NSDHL (Genemed Synthesis, San Francisco, CA). Anti-NSDHL antibodies were purified from the rabbit serum using a SulfoLink kit (Pierce, Rockford, IL) according to the manufacturer’s protocol. Phospho-histone H3 (PHH3) was detected in immunohistochemistry experiments using a rabbit polyclonal anti-PHH3 antibody (Cell Signaling Technology, Danvers, MA). β-tubulin was detected on immunoblots using rabbit polyclonal anti-β-tubulin antibodies (catalog number RB-9249-P0, Thermo Scientific, Fremont, CA).

Immunoblot analysis

For protein extracts, mouse embryonic fibroblasts were lysed and tissues were homogenized in RIPA buffer (150 mM NaCl, 10 mM Tris pH 7.2, 0.1% SDS, 1% Triton X-100, 1% deoxycholate, 5 mM EDTA). Protein concentration in the lysates was measured using the BCA Protein Assay Kit (Pierce, Rockford, IL). Proteins were resolved by SDS-PAGE and transferred to Hybond ECL membrane as previously described [11]. Preblocking, primary antibody binding and secondary antibody binding to immunoblots were carried out in TBST (10 mM Tris pH 7.0, 150 mM NaCl, 0.1% Tween-20) with 2% normal goat serum. The secondary antibody was HRP-linked anti-rabbit IgG (Cell Signaling, Danvers, MA). Antibody binding was visualized using SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL) and exposing the blots to X-Omat film (Kodak, Rochester, NY).


Mouse embryos and adult tissues were fixed overnight at 4° C in Bouin’s fixative and rinsed in 70% ethanol. Adult brains were fixed by transcardial whole-animal perfusion with Bouin’s fixative. Fixed tissues were embedded in paraffin blocks and sectioned at a thickness of 5 µm. After deparaffinization, slides were heated to 95° C for 20 min in antigen retrieval solution (10 mM sodium citrate, 0.05% Tween-20, pH 6). Slides were incubated with Peroxidase Blocking Reagent, Protein Block and primary antibody diluted to 1:500 in Antibody Diluent (Dako, Carpinteria, CA) according to the manufacturer’s instructions. Primary antibody binding was amplified using a Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA), including biotinylated anti-rabbit secondary antibody. Antibody binding was visualized using the Liquid DAB+ Substrate Chromogen System (Dako, Carpinteria, CA). Samples were counterstained for 1 min with hematoxylin. Photomicrographs were acquired with SPOT version 3.5 software operating SPOT RT Color digital cameras (Diagnostic Instruments, Sterling Heights, MI) mounted on a Nikon SMZ-10A microscope or a Nikon Eclipse E800 microscope. No adjustments were made in the color, contrast or hue of the photomicrographs. In experiments where the ratio of NSDHL stained vs unstained hepatocytes was measured and compared at different ages, statistically significant differences from the expected 1:1 ratio were determined using a one-sample t test.


Generation of a specific anti-NSDHL polyclonal antibody

A rabbit polyclonal antiserum was raised against a peptide corresponding to the 18 amino acids at the carboxy-terminus of the mouse NSDHL protein. Anti-NSDHL antibodies were affinity purified from the antiserum using the peptide immunogen and tested for specificity by immunoblotting (Fig. 1). Mouse NSDHL comprises 362 amino acids with a predicted molecular mass of 38 kD. A single band near the expected position on the blot was detected in a whole-cell lysate from WT MEFs. A lysate from Bpa1H MEFs served as a negative control. The truncated peptide that is predicted to be encoded by the Bpa1H allele lacks the carboxy-terminal region of NSDHL, and was not detected by our antibody (Fig. 1, lane 2). A replicate blot that was probed with an anti-β-tubulin antibody demonstrated equivalent protein concentration and integrity of the WT and Bpa1H MEF samples (Fig. 1, lower panel). The NSDHL antibody showed highly specific staining in total protein extracts from WT E16.5 embryo, adult liver and adult brain. A relatively faint band seen in the liver extract that migrated slightly faster than the 38 kD NSDHL band may be either a partial degradation product of NSDHL or nonspecific binding to another protein. However, since it represented a small proportion of the total signal in the sample, we concluded that the antibody would provide an informative reagent for immunohistochemical analysis of NSDHL expression in WT tissues, as well as distinguishing WT and mutant cells in mosaic Bpa1H female mice. The lack of detectable signal for β-tubulin in the liver extract is due, in part, to the relatively low level of tubulin expression in this tissue [23]. Faint β-tubulin signal was detected in this sample when loading was increased to 40 µg (not shown).

Figure 1
Detection of NSDHL in whole protein extracts by Western blot analysis using a purified anti-NSDHL polyclonal antibody

Embryonic expression pattern

In crosses between heterozygous Bpa1H females and WT males, 25% of the embryos are expected to be hemizygous Bpa1H males. In six litters of E7.5 embryos from this cross, we found 23% (9 out of 38) were Bpa1H males. No viable male Bpa1H embryos are found at E11.5 [13]. These data suggest that NSDHL is not required for preimplantation viability, but is essential for normal development around the time of gastrulation. NSDHL staining of WT embryos at E6.5 and E7.5 resulted in a relatively low and uniform level of signal throughout all cell-types (Supplemental Fig. 1). In E8.5 embryos, cells of the developing neural tube showed distinctly higher expression than those in other tissues (not shown). An increasingly complex expression pattern in the developing central nervous system (CNS) and peripheral neurons was evident in E10.5 embryos (Fig. 2A). Notably, the dorsal root ganglia (DRG) and differentiating motor neurons in the basal (ventral) column of the neural tube demonstrated intense staining (Fig. 2B, D). Strong expression of NSDHL was also detected in a subset of cells within the fetal liver (Fig. 2C). Since cholesterol is an essential component of the plasma membrane, we asked whether high NSDHL expression was associated with highly proliferative cells by staining with an anti-phosphorylated histone H3 (PHH3) antibody that detects mitotic cells. In the neural tube, numerous mitotic cells were seen in the ventricular layer, as expected. Few, if any PHH3 positive cells were seen in the differentiating neurons of the basal column that showed higher NSDHL expression (Fig. 2E, arrow). Thus, while NSDHL staining was present in dividing cells of the neurepithelium, a substantially higher signal was seen in specific subsets of differentiating neurons.

Figure 2
Developmental expression pattern of NSDHL in mouse embryos

In the E14.5 embryo, NSDHL expression was again prominent in the liver, DRG and the developing brain (Fig. 2F). The trigeminal ganglion and superior cervical ganglion also showed very high levels of NSDHL. In addition, the adrenal gland and Leydig cells of the testis, both of which are highly steroidogenic cell types, were intensely stained (Fig. 2G, Supplemental Fig. 2). Metanephric glomeruli and epithelial cells of metanephric tubules in the kidney, as well as epithelial cells of the intestine, showed moderately high levels of NSDHL. Strong expression was also seen in a layer of condensing mesenchyme surrounding developing ribs, specifically in the dorsal/caudal region of the embryo (Fig. 2H).

The pattern of NSDHL expression detected by immunostaining among tissues of the midgestation embryo was supported by in situ hybridization analysis of the E15.5 embryo using a radiolabeled antisense RNA probe that detected Nsdhl mRNA (Supplemental Fig. 3). High levels of Nsdhl transcripts were detected in the liver, brain, adrenal, cranial ganglia, and intestinal epithelium.

Since a Bpa1H heterozygous female would be expected to show mosaic NSDHL expression due to random X inactivation, we compared the staining pattern in the neopallial cortex (developing cerebral cortex) of a WT E14.5 embryo with that of a mutant embryo (Fig. 2I, J). The WT embryo showed a continuous band of stained neurons throughout the cortex, including evidence of signal in the dendrites of neurons (Fig. 2I). In the mutant embryo, patchy staining arranged in sectors that radiated out from the ventricular layer was present throughout the cortex (Fig. 2J). This pattern is consistent with a mixed population of WT and mutant progenitor cells in the ventricular layer giving rise to clonal populations of differentiating neurons that migrate away from the ventricle to populate the developing cerebral cortex.

A pattern similar to that found in the mutant neopallial cortex was seen in the embryonic retina. At E15.5, the WT eye showed strong staining for NSDHL in the ganglion cell layer (GCL), with lower signal throughout the neuroblast layer (NL) of the developing retina (Fig. 2K). This pattern was confirmed by in situ hybridization analysis that showed high levels of Nsdhl mRNA in the retina at E15.5. The GCL comprises proliferating stem cells that give rise to all neural cell types of the mature retina. In the Bpa1H female eye, the GCL included both NSDHL positive and negative cells (Fig. 2L). The differentiating cells of the NL showed sectors of stained and unstained cells radiating out from the GCL. These results demonstrate that mutant neural progenitor cells present in the fetal brain and eye give rise to differentiating neurons and that they migrate to the appropriate position in the developing tissue.


The mature liver is composed of structural subunits called lobules, defined primarily by the arrangement of their vasculature. Portal veins arranged in a ring transport blood into the lobule where it flows through sinusoids between cords of hepatocytes and drains into a central vein that carries blood out of the lobule. In the adult WT liver, staining for NSDHL produced strong signal in all hepatocytes. A slight zonal gradient of expression was evident, with the highest levels in the pericentral region of lobules (Fig. 3A). In livers from Bpa1H females over one year of age (13–14 mo), a mosaic pattern of staining in hepatocytes was observed (Fig. 3B, C, D).

Figure 3
Immunostaining of NSDHL in WT and Bpa1H liver

In the absence of selective pressure, WT and mutant cells would be expected to be present in roughly equal numbers due to random X-inactivation in early embryogenesis. However, a majority of hepatocytes were NSDHL positive in livers from adult Bpa1H females (Fig. 3B), with small clusters of unstained cells clearly distinguishable (Fig. 3C). To quantitate this skewed ratio, at least 1500 hepatocytes were scored as either NSDHL positive or negative in livers from 12 Bpa1H females over 1 year of age (13–14 mo). The mean percentage of WT hepatocytes in the 12 samples was 79 (SD: 10), significantly higher than the expected 50% (p<0.0001). In the affected livers that showed the highest (~40%) proportion of unstained hepatocytes (Fig. 3D), a nonrandom pattern of positive and negative hepatocytes was observed, with stained cells highly concentrated in pericentral region of the lobules (Fig. 3D). These results suggest that Bpa1H hepatocytes undergo negative selection in affected females, either due to a lower proliferation rate or increased cell death. Furthermore, this effect appears to depend, in part, on their position within the lobule.

Since NSDHL is expressed strongly in hepatocytes from early fetal stages through adulthood, we asked at what developmental stage the proportion of WT to mutant cells begins to deviate from the expected 1:1 ratio and show a nonrandom distribution in the liver. Staining of livers from P6 Bpa1H females revealed an apparently random distribution of positive and negative cells (Fig. 3E). The average percentage of NSDHL positive hepatocytes in livers from six Bpa1H P6 females was 52 (SD: 5). Among six mutant livers at P25, the average percentage of NSDHL positive hepatocytes increased to 62 (SD: 9). However, in contrast to the older livers, their distribution appeared to be nearly random throughout the lobules (Fig. 3F). Thus, the ratio of WT to mutant cells at P6 (52%) was not significantly different from the expected 1:1 (p=0.33). In P25 livers, the proportion of WT hepatocytes (62%) was significantly higher than 50% (p=0.017). These data suggest that the higher percentage of WT hepatocytes present in livers from older Bpa1H females is the cumulative result of postnatal differences in either the growth rate or survival of WT vs mutant hepatocytes.


In normal development, the onset of hair follicle development is marked by the induction of epidermal placodes at E14.5 [24]. Stratification and differentiation of the epidermis occurs between E14.5 and E18.5 [25]. In WT embryos at E16.5, NSDHL staining was visible in the outermost layer of the epidermis, with little or no staining in the developing hair follicles (Supplemental Fig. 4). Regions of NSDHL negative and positive skin were detected in Bpa1H female embryos, consistent with the expected mosaic expression pattern. The NSDHL positive and negative areas in the Bpa1H mosaic skin were histologically similar to each other and to that of entirely WT embryos (Supplemental Fig. 4).

Figure 4
NSDHL expression in developing dorsal skin and hair follicles

In WT dorsal skin at P2, NSDHL expression showed a distinct pattern within the developing hair follicles (Fig. 4A). Staining was strongest in the sebaceous glands, with moderate staining also present in the matrix and inner root sheath. Staining was not observed in the outer root sheath at the level between the arrector pili muscle and the sebaceous gland, the hair follicle stem cell niche known as the bulge. Low level NSDHL expression was seen in the epidermis. In a Bpa1H littermate, the epidermis and hair follicles appeared to be morphologically normal in regions that lacked NSDHL staining, indicating that hair follicle morphogenesis is not grossly abnormal in Bpa1H mutant skin at this stage (Fig. 4B).

In WT dorsal skin at P6, when hair shafts had emerged from the follicles, NSDHL staining was very strong in the inner and outer root sheaths in the non-permanent segment of the hair follicle below the insertion of the arrector pili muscle, as well as the sebaceous glands (Fig. 4C, E). The mosaic expression of NSDHL was evident in skin from a Bpa1H female littermate (Fig. 4D, F). A low magnification view of alternating regions of NSDHL positive and negative hair follicles revealed that a lack of NSDHL expression resulted in arrested downgrowth of the follicles, indicative of impaired progression through the anagen hair cycle within the mutant areas of skin (Fig. 4D). The mutant follicles were smaller and shorter than adjacent WT follicles and lacked hair shafts, consistent with defective anagen hair growth. A higher magnification view of an NSDHL negative region showed a thickened epidermis with cystic invaginations reminiscent of utricles, and a thickened dermis with inflammatory infiltrate (Fig. 4F). Hyperkeratotic material could be visualized in the cystic structures.

The bands of hyperkeratotic eruptions that characterize the skin of Bpa1H females at 1 week of age resolve to narrow stripes of hairless skin after several weeks. In the dorsal skin from an 8 week old Bpa1H female that showed relatively large stripes of affected skin, NSDHL staining revealed clear domains of positive and negative tissue (Fig. 4G). In the positively stained regions, hair follicles showed strong staining in the inner and outer root sheaths below the arrector pili muscle as well as the matrix region of the hair bulb. Sebaceous glands were strongly positive and the epidermis was weakly positive for NSDHL, as in the skin from P2 and P6 pups. In the NSDHL negative skin, hair shafts were absent and the hair follicles appeared to be in the telogen stage of the hair cycle despite the predominance of anagen stage follicles in the adjacent WT skin. Although the majority of follicles in the mutant patches appeared to be in telogen, a few scattered deeper follicular units consistent with anagen follicles were observed. The sebaceous glands associated with the predominantly telogen follicles in the mutant regions appeared enlarged, similar to the phenotype of other mouse mutants that display sebaceous gland hyperplasia in the context of alopecia [26, 27]. The general lack of anagen hair follicles in the mature Bpa1H skin lesions resembled the phenotype seen in the P6 skin. The dermis in the mature affected skin was marked by the presence of amorphous debris that was noted in previous studies of Bpa1H skin [14].


The cholesterol concentration of the adult mouse brain is about 7-fold higher than the average cholesterol concentration of the whole animal [19]. Because cholesterol is not transported across the blood-brain barrier, cholesterol biosynthesis within the brain is essential for its normal growth and development [28]. In the postnatal mouse, the rate of cholesterol synthesis in the CNS is highest (300–400 nmol/hr) during the first three weeks after birth, after which it drops about 6-fold and stabilizes at 10–13 weeks of age [29]. In light of the substantial age-dependent differences in rates of cholesterol biosynthesis, we first identified which cells express NSDHL in the WT brain during early postnatal development and in the adult. We then asked whether NSDHL negative cells were present in these cell populations in Bpa1H mutant female pups and adults.

In WT brain at P2, the distribution of cells expressing NSDHL was complex, with at least some positive cells in virtually all regions. However, broad patterns of relatively high expression were evident. Staining was prominent in a wide band of differentiating neurons in the cortical plate of the cerebrum (Fig. 5A, C). As noted in developing neurons of the E14.5 embryo (Fig. 2I), the cell bodies as well as dendrites were stained. Pronounced NSDHL signal was also present in hippocampal neurons (Fig. 5E). In the cerebellum, staining was strongest in the layer of cells composed of Purkinjie cell precursors and Bergmann glia (not shown). Because Purkinjie cells do not display a fully differentiated morphology at P2, we were not able to determine whether one or both cell types are positive for NSDHL at this stage. Distinct staining was also seen in cells throughout the thalamus (Fig. 5E) and in the mitral layer neurons in the developing olfactory bulb (Fig. 5A, see arrow). Regions that showed relatively low staining included the intermediate cortical layer and subventricular layers of the cerebrum, the dentate gyrus, granular cells of the developing striatum (caudate putatem), granular cells of the olfactory bulb, the superior colliculus and the choroid plexus.

Figure 5
NSDHL in early postnatal and adult brains of WT and Bpa1H females

In the Bpa1H female P2 brain, a mosaic pattern of NSDHL staining was most evident in the cerebrum and hippocampus (Fig. 5B, D, F). In the cerebrum, radiating sectors of NSDHL positive and negative neurons were visible in a pattern similar to that seen in the Bpa1H E14.5 embryo (compare Fig. 2J and Fig. 5D). Likewise, the P2 mutant hippocampus was composed of a mixture of stained and unstained cells throughout its length (Fig. 5F), in contrast to the WT hippocampus that showed regions where virtually all of the cells were NSDHL positive (Fig. 5E). A similar pattern was observed in the hippocampus of WT and Bpa1H female brains at P25 (Supplemental Fig. 5, Panels A–D). Although the overall intensity of NSDHL staining in hippocampal neurons was lower in P25 brains than P2 brains, the WT hippocampus was evenly stained throughout its length, while the Bpa1H hippocampus was composed of both stained and unstained neurons. These results suggest that a substantial number of NSDHL deficient neurons survive to birth in the Bpa1H female, presumably acquiring cholesterol from WT neurons and/or glia.. We were not able to assess the extent of mosaicism in other regions of the Bpa1H brain due to the heterogeneous levels of NSDHL staining seen among different cell types in these or the same regions of the WT brain.

The general pattern of NSDHL staining in the WT brain at 1 year of age resembled that of the P2 brain in that signal was most pronounced in the cerebral cortex and CA1 and CA3 regions of the hippocampus (Fig. 5G, I). This profile is in agreement with data provided in the Allen Brain Atlas for Nsdhl gene expression in the WT mouse brain using in situ hybridization analysis ( We also observed positive cells dispersed throughout white and gray matter, displaying a morphology consistent with glial cells. NSDHL staining in the adult brain differed from the neonatal brain in two major ways. First, overall, the proportion of strongly positive cells was lower in the adult. For example, in the adult cerebral cortex, a narrow layer of large pyramidal neurons showed distinct staining (Fig. 5G, arrow), in contrast to the much broader band of differentiating cortical neurons in the P2 brain (Fig. 5C). The relatively large size of the nuclei and cell bodies of these adult neurons, as well as their position, are consistent with layer V of the cerebral cortex. The second distinguishing feature of the adult brain, is that signal was visible mainly in the cell bodies of neurons, with much fainter staining in the dendrites (compare cortical neurons at P2, Fig. 5C, with adult cortical neurons, Fig. 5G).

At a gross level, the Bpa1H adult brain was indistinguishable from the WT brain with regard to the pattern of NSDHL staining (Fig. 5H, J). No patches of unstained neurons were observed in the layer of NSDHL positive cortical neurons or in the CA1 and CA3 regions of the hippocampus, as was seen in the P2 Bpa1H brain. Upon close examination, only a few NSDHL negative hippocampal neurons could be seen among the hundreds of positive cells within the CA1 and CA3 regions that were visible on each section (Supplemental Fig. 5F), suggesting that the mutant neurons are subject to negative selection over the life of the animal. Due to the wide variation in levels of NSDHL expression among neurons of the WT cerebrum, it was not possible to determine whether a small number of mutant cells were present among the positive cells in the Bpa1H adult brain. This grossly WT pattern of NSDHL signal was present in brains from three Bpa1H females at 1 year of age.


While cholesterol biosynthesis is a fundamental housekeeping function shared by most, if not all, cell types, the activity level of the pathway varies widely among different tissues [30, 31]. This variation may reflect different requirements for either functional intermediate molecules in the pathway, cholesterol itself, or cholesterol as a precursor for the synthesis of steroid hormones or neurosteroids. Analyses of the consequences of perturbing the pathway at various steps may allow these multiple functions to be distinguished. Because cholesterol can be acquired through dietary intake and transported via lipoproteins in the serum, a primary question in understanding the pathologies associated with disorders of cholesterol synthesis in humans is whether they result from cholesterol deficiency per se, a deficiency of key precursor molecules, or the abnormal accumulation of sterol intermediates to toxic levels due to a block in the pathway. Testing these hypotheses is complicated by the fact that sterol intermediates that share the greatest structural similarity to cholesterol, such as desmosterol and 7-DHC, can incorporate into cell membranes. However, substitution of cholesterol with desmosterol or 7DHC alters the physical properties of membranes, impairs lipid raft-dependent signaling, and alters the structure and function of caveolae [3234]. This partial functional overlap with cholesterol probably accounts for the survival to birth of mouse embryos that are homozygous for null mutations in Dhcr24 and Dhcr7, in contrast to the much earlier embryonic lethality of mutations in enzymes such as squalene synthase and NSDHL that block earlier steps in the pathway [35, 36].

Previously, we compared the survival of Bpa1H vs WT cells in vitro by sorting and counting mutant and WT cells in primary cultures of MEFs from Bpa1H female E15.5 embryos [20]. We found no evidence of negative selection acting on mutant cells in utero, since on average they were present in proportions equivalent to WT cells at the time they were isolated. In a mixed population of MEFs, the ratio of mutant to WT cells did not change significantly after nine passages in culture. Sorted populations of mutant and WT cells grew equally well in the presence of 10% normal fetal bovine serum. However, in the presence of delipidated serum, most of the cells in a pure Bpa1H population died within 48 hrs. WT cells did not show cell death in delipidated serum. Finally, when cultured with WT MEFs in delipidated medium, the Bpa1H cells showed no cell death after 48 hrs, suggesting that the mutant cells were rescued by presence of WT cells. Our analysis of heterozygous Bpa1H female mice, that are randomly mosaic for WT and NSDHL deficient cells, allowed us to ask similar questions in vivo.

Varying levels of NSDHL expression among different cell types were apparent in WT E10.5 embryos with the highest signal found in the CNS, DRG and fetal liver. Within the CNS, differentiating motor neurons of the neural tube showed the most intense staining (Fig. 2F). The DRG of the peripheral nervous system were also strongly stained for NSDHL. These results are consistent with a previous study of the expression of cholesterogenic enzymes in the mouse embryo using whole-mount in situ hybridization, where strong Nsdhl mRNA expression was detected in the DRG and neural tube at E10.5 [37]. A reason for the relatively high CNS expression that was evident at this stage may be the formation of the blood-brain barrier. Maternally derived cholesterol accounts for a substantially lower proportion of the total cholesterol in the fetal brain than other fetal tissues after E10, as demonstrated by sterol measurements in Dhcr7 −/− embryos and levels of isotopically labeled cholesterol injected into dams that was measured in fetal organs [38, 39]. Further, the relatively high level of NSDHL that was observed particularly in differentiating neurons may be due, in part, to a requirement for cholesterol in the large amount of plasma membrane required for the growing dendrites and axons of these cells. Finally, neurons of the CNS and peripheral nervous system, including the DRG, trigeminal ganglion, superior cervical ganglion and ganglion cell layer of the retina, synthesize neurosteroids from cholesterol, as demonstrated by the expression and activity in these cells of P450scc, a mitochondrial enzyme that initiates the conversion of cholesterol to pregnenolone [40, 41].

The clonal sectors of NSDHL negative cells that were visible in the fetal brain and retina of Bpa1H embryos demonstrated that mutant progenitor cells were able to proliferate, migrate and begin to differentiate morphologically. This raises the question as to what extent these cells are able to differentiate and function relative to WT cells. Further studies that employ cell type specific markers and functional assays will be required to resolve this question in various tissues.

The liver provided a convenient organ in which to measure the long term survival of mutant cells in the Bpa1H female. It comprises a relatively homogeneous population of hepatocytes that showed high expression of NSDHL at all stages of development, facilitating the quantitation of mutant and WT cells at different ages. The increased proportion of WT hepatocytes (79%) observed at one year of age relative to that at P6 (52%) suggests that the mutant cells are preferentially lost over the life of the adult animal. The nonrandom distribution of mutant and WT cells in the adult Bpa1H liver, where WT cells preferentially occupy the pericentral region of the lobule, is consistent with the notion that mutant cell death accounts, at least in part, for the skewed ratio. Although it was once thought that hepatocyte proliferation is localized to the periportal region of the lobule and that cells migrate toward the pericentral zone, more recent analyses that use cell lineage tracers and radiolabeling indicate that hepatocytes do not migrate in an organized pattern and that proliferation does not occur in a particular region of the lobule [42, 43]. Thus, the nonrandom distribution of mutant and WT cells in the Bpa1H adult liver is probably not caused by differential migration of the hepatocytes, although we cannot definitively exclude this model.

Another hypothesis is that mutant cells divide more slowly than WT cells in the pericentral region. If this were the case, we would expect to see patches of NSDHL negative cells similar to those in the pericentral region of the P25 liver present in this region of the older liver. Instead, mutant cells were virtually absent from the pericentral region in the older livers, and were usually found as individual cells or clusters smaller than in the P25 liver. Thus, we favor the hypothesis that the mutant cells die at a slightly higher rate in the pericentral region than in the periportal region of the lobule. This may be due to a greater accumulation of potentially cytotoxic sterol precursors caused by the Bpa1H block to cholesterol biosynthesis in pericentral cells if they are programmed to synthesize cholesterol at a higher rate than periportal hepatocytes.

The apparent negative selection of mutant cells in the mosaic Bpa1H liver was in contrast to our previous results that found no evidence of selection against the mutant cells in a mixed population of MEFs [20]. This discrepancy may be due to differences between fibroblasts in vitro and hepatocytes in vivo with regard to their rate of cholesterol biosynthesis, mechanisms of cholesterol efflux and import, or susceptibility to the possible deleterious effects of increased levels of sterol precursors. An understanding of why negative selection in the liver and other tissues is apparently more pronounced after birth than during embryogenesis will require additional experiments that investigate the role of maternal cholesterol in the development of Bpa1H and wild type embryos.

Previous studies have shown that the skin is a site of significant cholesterol biosynthesis [30, 44]. In the stratum corneum of the epidermis, cholesterol is a one of several secreted lipids present in lamellar bodies that form a permeability barrier that prevents trans-epidermal water loss [45]. The source of the barrier cholesterol is thought to be mainly the epidermis and is independent of circulating cholesterol [46]. Mice that lack DHCR24, the enzyme that catalyzes the conversion of desmosterol to cholesterol, die within several hours after birth and show defects in the maturation of the epidermis, with compromised barrier function [47]. The skin of Dhcr24 −/− pups is marked by hyperproliferation of immature keratinocytes. However, an inflammatory infiltrate in the dermis, such as that seen in the Bpa1H skin, was not reported. Mice that lack DHCR7 also die within the first day of life, but have no reported skin abnormalities [4, 6]. These results may reflect a difference in the ability of the sterol precursors desmosterol and 7-DHC to partially substitute for cholesterol in epidermal development and barrier function. Due to the perinatal lethality caused by these null alleles, their effect on hair follicle maturation is not known. However, some partially rescued Dhcr7 −/− mice that carry a WT Dhcr7 transgene under the control of the CNS-specific nestin promoter survive to P17 and have no reported skin or hair abnormalities [48].

Although barrier function was not tested in the skin of Bpa1H mutants, we saw no gross morphological or histological abnormalities in the epidermis within NSDHL negative regions of the mosaic skin of pups at P2. The timing of the appearance of hyperkeratotic eruptions in Bpa1H females at P6 coincided with the stage at which hair shafts emerge from the maturing follicles in WT skin. The strong expression of NSDHL seen in the maturing follicles, along with the short, immature appearance of hair follicles in the NSDHL negative areas of skin at P6 and in the 8 week old adult suggest that products from the endogenous cholesterol biosynthetic pathway are required for the completion of hair follicle development. Although the role of cholesterol biosynthesis in hair follicle development is not clear, it is known that human hair follicles possess high HMGCR activity, at a level roughly 70% of that found in human liver cells [49]. Moreover, HMGCR activity in human hair follicles is not sensitive to either naturally occurring or experimentally induced changes in the level of exogenous LDL [49]. This suggests that, unlike many other tissues, hair follicles do not acquire cholesterol from plasma. Isolated apocrine and sebaceous glands, by contrast, show reduced HMGCR activity in response to the presence of exogenous cholesterol, indicating that they are able to take up plasma lipids [50]. The relative autonomy of hair follicles with regard to cholesterol synthesis may explain why, in affected Bpa1H skin, they fail to develop fully, particularly in the cycling segment of the follicle where NSDHL expression is highest.

In the mouse, the brain roughly doubles in weight between 1 and 26 weeks of age. At the same time, the cholesterol content of the brain increases more than 6-fold [29]. The first three weeks after birth are marked by the highest rate of brain cholesterol synthesis. In the adult mouse, about 80% of the total brain cholesterol is in myelin that is synthesized by oligodendrocytes to provide insulating sheathes for neuronal axons and dendrites. While it is known that astrocytes synthesize cholesterol that is transported to neurons, the relative contribution of endogenous neuronal cholesterol biosynthesis vs transport from glial cells throughout development and maturation of the brain is not clear [51]. Previous studies have demonstrated that cultured neurons synthesize cholesterol [52]. Recently, it has been reported that de novo cholesterol biosynthesis in neurons is regulated by brain-derived neurotrophic factor (BDNF) and p75 neurotrophin receptor, based on changes in the expression levels of cholesterogenic enzymes [53, 54]. In neurons, cholesterol-rich lipid rafts and caveolae are thought to play important roles in synaptogenesis and signal transduction that vary among different types of neurons [55, 56].

Our analysis of the WT P2 brain showed that NSDHL is expressed at high levels in cortical neurons and the hippocampus. Consistent with the known decrease in the rate of cholesterol synthesis in mature animals, we observed both lower levels and a more restricted distribution of staining in the adult brain. The relatively broad sectors of NSDHL deficient cells, presumably including both neurons and glia, that were observed in the Bpa1H brain at P2 suggest that these cells were able to acquire sufficient cholesterol by transport from WT cells to survive to birth. The apparent loss of these sectors in the adult mutant may be the result of negative selection during the period of high demand for cholesterol in the CNS during the first month of life, defects in synaptogenesis or prosurvival signaling, or the accumulation of toxic sterol intermediates due to the upregulation of the cholesterol biosynthetic pathway in the young adult. The lack of gross structural abnormalities in the Bpa1H adult hippocampus implies that substantial numbers of cells may be lost between birth and maturity, although it is possible that some or all of these neurons may be replaced by proliferating neural progenitor cells that reside within the subgranular zone of the dentate gyrus and subventricular zone of the lateral ventricles [57]. Distinguishing between these possibilities and determining whether negative selection acts on all of the mutant cells in the Bpa1H brain or only cells with a relatively high rate of endogenous cholesterol biosynthesis will require further investigation using conditional gene disruption approaches.

Supplementary Material





We thank Dr. Kim McBride for performing statistical analysis. This work was supported by NIH R01 HD38572 to G.E.H.


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.


1. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31–39. [PubMed]
2. Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008 Sep;:125–138. [PubMed]
3. Jeong J, McMahon AP. Cholesterol modification of Hedgehog family proteins. J Clin Invest. 2002;110:591–596. [PMC free article] [PubMed]
4. Wassif CA, Zhu P, Kratz L, Krakowiak PA, Battaile KP, Weight FF, Grinberg A, Steiner RD, Nwokoro NA, Kelley RI, Stewart RR, Porter FD. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith--Lemli--Opitz syndrome. Hum Mol Genet. 2001;10:555–564. [PubMed]
5. Ohashi K, Osuga J, Tozawa R, Kitamine T, Yagyu H, Sekiya M, Tomita S, Okazaki H, Tamura Y, Yahagi N, Iizuka Y, Harada K, Gotoda T, Shimano H, Yamada N, Ishibashi S. Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene. J Biol Chem. 2003;278:42936–42941. [PubMed]
6. Fitzky BU, Moebius FF, Asaoka H, Waage-Baudet H, Xu L, Xu G, Maeda N, Kluckman K, Hiller S, Yu H, Batta AK, Shefer S, Chen T, Salen G, Sulik K, Simoni RD, Ness GC, Glossmann H, Patel SB, Tint GS. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J Clin Invest. 2001;108:905–915. [PMC free article] [PubMed]
7. Herman GE. Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes. Hum Mol Genet. (No 1) 2003;12(Spec):R75–R88. [PubMed]
8. Kelly DL, Rizzino A. DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells. Mol.Reprod.Dev. 2000;56:113–123. [PubMed]
9. Waterham HR. Defects of cholesterol biosynthesis. FEBS Lett. 580;2006:5442–5449. [PubMed]
10. Liu XY, Dangel AW, Kelley RI, Zhao W, Denny P, Botcherby M, Cattanach B, Peters J, Hunsicker PR, Mallon AM, Strivens MA, Bate R, Miller W, Rhodes M, Brown SD, Herman GE. The gene mutated in bare patches and striated mice encodes a novel 3beta-hydroxysteroid dehydrogenase. Nat Genet. 1999;22:182–187. [PubMed]
11. Caldas H, Herman GE. NSDHL, an enzyme involved in cholesterol biosynthesis, traffics through the Golgi and accumulates on ER membranes and on the surface of lipid droplets. Hum Mol Genet. 2003;12:2981–2991. [PubMed]
12. Phillips RJ, Hawker SG, Moseley HJ. Bare-patches, a new sex-linked gene in the mouse, associated with a high production of XO females. I. A preliminary report of breeding experiments. Genet Res. 1973;22:91–99. [PubMed]
13. Caldas H, Cunningham D, Wang X, Jiang F, Humphries L, Kelley RI, Herman GE. Placental defects are associated with male lethality in bare patches and striated embryos deficient in the NAD(P)H Steroid Dehydrogenase-like (NSDHL) Enzyme Mol Genet Metab. 2005;84:48–60. [PubMed]
14. Emami S, Hanley KP, Esterly NB, Daniallinia N, Williams ML. X-linked dominant ichthyosis with peroxisomal deficiency: an ultrastructural and ultracytochemical study of the Conradi-Hunermann syndrome and its murine homologue, the bare patches mouse. Arch.Dermatol. 1994;130:325–336. [PubMed]
15. Happle R, Phillips RJS, Roessner A, Junemann G. Homologous genes for X-linked chondrodysplasia punctata in man and mouse. Hum.Genet. 1983;63:24–27.. [PubMed]
16. Konig A, Happle R, Bornholdt D, Engel H, Grzeschik K-H. Mutations in the NSDHL gene, encoding a 3β-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet. 2000;90:339–346. [PubMed]
17. Happle R, Koch H, Lenz W. The CHILD syndrome. Congenital hemidysplasia with ichthyosiform erythroderma and limb defects. Eur.J.Pediatr. 1980;134:27–33. [PubMed]
18. Grange DK, Kratz LE, Braverman N, Kelley RI. CHILD syndrome caused by deficiency of 3β-hydroxysteroid-Δ8, Δ7-isomerase. Am.J.Med.Genet. 2000;90:328–335. [PubMed]
19. Dietschy JM, Turley SD. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004;45:1375–1397. [PubMed]
20. Cunningham D, Swartzlander D, Liyanarachchi S, Davuluri RV, Herman GE. Changes in gene expression associated with loss of function of the NSDHL sterol dehydrogenase in mouse embryonic fibroblasts. J Lipid Res. 2005;46:1150–1162. [PubMed]
21. Mroz K, Hassold TJ, Hunt PA. Meiotic aneuploidy in the XXY mouse: evidence that a compromised testicular environment increases the incidence of meiotic errors. Hum Reprod. 1999;14:1151–1156. [PubMed]
22. Angel T, Faust C, Gonzales JC, Kenwrick S, Lewis RA, Herman GE. Genetic mapping of the X-linked dominant mutations striated (Str) and bare patches (Bpa) to a 600-kb region of the mouse X Chromosome: implications for mapping human disorders in Xq28. Mamm. Genome. 1993;4:171–176. [PubMed]
23. Vallejo CG, Seguido AM, Testillano PS, Risueno MC. Thyroid hormone regulates tubulin expression in mammalian liver. Effects of deleting thyroid hormone receptor-alpha or -beta. Am J Physiol Endocrinol Metab. 2005;289:E87–E94. [PubMed]
24. Schneider MR, Schmidt-Ullrich R, Paus R. The hair follicle as a dynamic miniorgan. Curr Biol. 2009;19:R132–R142. [PubMed]
25. O'Shaughnessy RF, Christiano AM. Inherited disorders of the skin in human and mouse: from development to differentiation. Int J Dev Biol. 2004;48:171–179. [PubMed]
26. Bol DK, Rowley RB, Ho CP, Pilz B, Dell J, Swerdel M, Kiguchi K, Muga S, Klein R, Fischer SM. Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development. Cancer Res. 2002;62:2516–2521. [PubMed]
27. Waikel RL, Kawachi Y, Waikel PA, Wang XJ, Roop DR. Deregulated expression of c-Myc depletes epidermal stem cells. Nat Genet. 2001;28:165–168. [PubMed]
28. Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001;12:105–112. [PubMed]
29. Quan G, Xie C, Dietschy JM, Turley SD. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res Dev Brain Res. 2003;146:87–98. [PubMed]
30. Turley SD, Andersen JM, Dietschy JM. Rates of sterol synthesis and uptake in the major organs of the rat in vivo. J Lipid Res. 1981;22:551–569. [PubMed]
31. Spady DK, Dietschy JM. Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. J Lipid Res. 1983;24:303–315. [PubMed]
32. Shrivastava S, Paila YD, Dutta A, Chattopadhyay A. Differential effects of cholesterol and its immediate biosynthetic precursors on membrane organization. Biochemistry. 2008;47:5668–5677. [PubMed]
33. Vainio S, Jansen M, Koivusalo M, Rog T, Karttunen M, Vattulainen I, Ikonen E. Significance of sterol structural specificity. Desmosterol cannot replace cholesterol in lipid rafts. J Biol Chem. 2006;281:348–355. [PubMed]
34. Jansen M, Pietiainen VM, Polonen H, Rasilainen L, Koivusalo M, Ruotsalainen U, Jokitalo E, Ikonen E. Cholesterol substitution increases the structural heterogeneity of caveolae. J Biol Chem. 2008;283:14610–14618. [PubMed]
35. Tozawa R, Ishibashi S, Osuga J, Yagyu H, Oka T, Chen Z, Ohashi K, Perrey S, Shionoiri F, Yahagi N, Harada K, Gotoda T, Yazaki Y, Yamada N. Embryonic lethality and defective neural tube closure in mice lacking squalene synthase. J Biol Chem. 1999;274:30843–30848. [PubMed]
36. Krakowiak PA, Wassif CA, Kratz L, Cozma D, Kovarova M, Harris G, Grinberg A, Yang Y, Hunter AG, Tsokos M, Kelley RI, Porter FD. Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency. Hum Mol Genet. 2003;12:1631–1641. [PubMed]
37. Laubner D, Breitling R, Adamski J. Embryonic expression of cholesterogenic genes is restricted to distinct domains and colocalizes with apoptotic regions in mice. Brain Res Mol Brain Res. 2003;115:87–92. [PubMed]
38. Tint GS, Yu H, Shang Q, Xu G, Patel SB. The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols. J Lipid Res. 2006;47:1535–1541. [PMC free article] [PubMed]
39. Yoshida S, Wada Y. Transer of maternal cholesterol to embryo and fetus in pregnant mice. J Lipid Res. 2005;46:2168–2174. [PubMed]
40. Guarneri P, Guarneri R, Cascio C, Pavasant P, Piccoli F, Papadopoulos V. Neurosteroidogenesis in rat retinas. J Neurochem. 1994;63:86–96. [PubMed]
41. Compagnone NA, Bulfone A, Rubenstein JL, Mellon SH. Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous systems during rodent embryogenesis. Endocrinology. 1995;136:2689–2696. [PubMed]
42. Magami Y, Azuma T, Inokuchi H, Kokuno S, Moriyasu F, Kawai K, Hattori T. Cell proliferation and renewal of normal hepatocytes and bile duct cells in adult mouse liver. Liver. 2002;22:419–425. [PubMed]
43. Bralet MP, Branchereau S, Brechot C, Ferry N. Cell lineage study in the liver using retroviral mediated gene transfer. Evidence against the streaming of hepatocytes in normal liver. Am J Pathol. 1994;144:896–905. [PubMed]
44. Feingold KR, Brown BE, Lear SR, Moser AH, Elias PM. Localization of de novo sterologenesis in mammalian skin. J Invest Dermatol. 1983;81:365–369. [PubMed]
45. Feingold KR. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res. 2007;48:2531–2546. [PubMed]
46. Andersen JM, Dietschy JM. Regulation of sterol synthesis in 15 tissues of rat. II. Role of rat and human high and low density plasma lipoproteins and of rat chylomicron remnants. J Biol Chem. 1977;252:3652–3659. [PubMed]
47. Mirza R, Hayasaka S, Takagishi Y, Kambe F, Ohmori S, Maki K, Yamamoto M, Murakami K, Kaji T, Zadworny D, Murata Y, Seo H. DHCR24 gene knockout mice demonstrate lethal dermopathy with differentiation and maturation defects in the epidermis. J Invest Dermatol. 2006;126:638–647. [PubMed]
48. Yu H, Wessels A, Tint GS, Patel SB. Partial rescue of neonatal lethality of Dhcr7 null mice by a nestin promoter-driven DHCR7 transgene expression. Brain Res Dev Brain Res. 2005;156:46–60. [PubMed]
49. Brannan PG, Goldstein JL, Brown MS. 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human hair roots. J Lipid Res. 1975;16:7–11. [PubMed]
50. Smythe CD, Greenall M, Kealey T. The activity of HMG-CoA reductase and acetyl-CoA carboxylase in human apocrine sweat glands, sebaceous glands, and hair follicles is regulated by phosphorylation and by exogenous cholesterol. J Invest Dermatol. 1998;111:139–148. [PubMed]
51. Pfrieger FW. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? Bioessays. 2003;25:72–78. [PubMed]
52. Vance JE, Campenot RB, Vance DE. The synthesis and transport of lipids for axonal growth and nerve regeneration. Biochim Biophys Acta. 2000;1486:84–96. [PubMed]
53. Korade Z, Mi Z, Portugal C, Schor NF. Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain. Neurobiol Aging. 2007;28:1522–1531. [PubMed]
54. Suzuki S, Kiyosue K, Hazama S, Ogura A, Kashihara M, Hara T, Koshimizu H, Kojima M. Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. J Neurosci. 2007;27:6417–6427. [PubMed]
55. Korade Z, Kenworthy AK. Lipid rafts, cholesterol, and the brain. Neuropharmacology. 2008;55:1265–1273. [PMC free article] [PubMed]
56. Ko M, Zou K, Minagawa H, Yu W, Gong JS, Yanagisawa K, Michikawa M. Cholesterol-mediated neurite outgrowth is differently regulated between cortical and hippocampal neurons. J Biol Chem. 2005;280:42759–42765. [PubMed]
57. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell. 2008;132:645–660. [PubMed]